Technical invention portfolio

Patents & invention lineages

My work spans automated cell-therapy manufacturing, scientific instrumentation, optoelectronics, microfluidics, single-cell analysis, and workflow automation. The portfolio is organized into 19 primary invention lineages, while each identified U.S. continuation and divisional publication is shown individually because later-filed claims can protect distinct inventions.

19 Primary invention lineages
26 Granted U.S. patents identified
42 Published U.S. applications identified
68 Identified U.S. patent publications

Cellares · Lineages 1–9

Automated cell-therapy manufacturing

Platform architecture, automated workflows, cell sorting, fluid handling, scheduling, analytics, and bioprocessing for integrated cell-therapy manufacturing systems.

01

Cell-Processing Platform

A shared priority lineage with distinct claim branches covering the integrated processing system and its reusable sterile fluid connector.

Priority 2020 · 10 U.S. publications · two claim branches shown in full

Claim branch · Systems and methods for cell processing

Claim branch · Fluid connector

International filing · Shared specification

02

Systems, Devices, and Methods for Cell Processing

Modular docking stations and cartridge modules for performing coordinated cell-processing operations.

Priority 2022 · separate invention lineage

04

Scheduling Workflows for Automated Cell-Therapy Manufacturing

Scheduling and coordination of manufacturing operations across automated workcells.

Priority 2023

05

Parallel Workflows in Automated Cell Processing

Parallelization and coordination of cell-processing operations.

Priority 2023

06

Conditional Execution of Automatic Cell Processing

Decision logic for adapting automated workflows to process state and results.

Priority 2023

07

Fluid Control in a Cell Processing System

Fluid routing, control, and handling within an automated processing platform.

Priority 2023

08

Pressure-Assisted Fluid Transfer and Sample Analysis

Pressure-controlled transfer and analysis inside a cell-processing system.

Priority 2024

09

Systems, Devices, and Methods for Bioprocessing

Integrated devices and workflows for controlled bioprocessing operations.

Priority 2024

Berkeley Lights · Lineages 10–18

Single-cell microfluidics & optoelectronics

Foundational platform IP spanning electrokinetic manipulation, optoelectronic systems, microfluidic isolation, cell culture, assay workflows, and recovery of selected cells.

12

Microfluidic Isolation and Sequestration Pens

Structures and methods for isolating, culturing, and testing biological micro-objects.

Priority 2013 · 7 U.S. publications · continuation chain shown in full

13

Exporting Selected Micro-Objects from a Microfluidic Device

Selection and recovery of specific cells or other micro-objects from a device.

Priority 2013 · 7 U.S. publications · continuation chain shown in full

14

Capturing Specific Nucleic Acids from Individual Biological Cells

Single-cell isolation and capture of targeted nucleic-acid material.

Priority 2013 · 3 U.S. publications · continuation included

17

Microfluidic Devices for Assaying Biological Activity

On-device biological assays and analysis of isolated micro-objects.

Priority 2013 · 8 U.S. publications · continuation chain shown in full

Oxford Gene Technology · Lineage 19

Single-cell capture devices

Early-career invention work in microfluidic capture and analysis of individual cells and other particles.

19

Picowell Capture Devices for Analysing Single Cells or Other Particles

Picowell-based capture, isolation, and analysis of individual cells and particles.

Priority 2009 · 1 U.S. publication

About this list. This page organizes the portfolio into 19 primary invention lineages using earliest priority and common subject matter, but it does not treat continuations or divisionals as mere duplicates. All 68 identified U.S. publications naming me as an inventor are listed individually because a later filing can protect a distinct claimed invention even when it shares priority with an earlier application. Representative PCT publications and selected regional records are also included; routine national translations and administrative validations are omitted. Counts and public-record statuses were reviewed on July 29, 2026 and are informational, not legal conclusions.